Our holding company Medicskin Holdings Limited (stock code 8307.HK) was listed on the Hong Kong Stock Exchange Limited GEM in 2014. We are a medical skincare group that operates two Medicskin centers focusing mainly on skin treatment in Hong Kong. We provide our clients with skin care services designed to treat a variety of skin problems (including but not limited to) acne, spots, rosacea, dermatitis, eczema and warts), as well as skin rejuvenation, facial contouring and body shaping treatments, treatment of acne scars and enlarged pores, removal of unwanted moles and hair removal to improve appearance. Our range of services includes: Advisory services Depending on the customer's specific needs, requirements, and skin conditions, we will diagnose or recommend skincare products or treatments. Treatment services All treatment devices used to treat our clients are evaluated and evaluated by our team for use based on certain selection criteria, including whether these devices are evidence-based and/or supported by independent medical journals and/or approved by national government agencies, such as FDA/MFDS/CE/KFDA, etc., to ensure they are safe and secure. Precise preventive care We partner with biotech diagnostic companies to provide customers with a range of genetic tests, including genetic risk assessments, precision cancer tests, ct-DNA early cancer screening tests, female health tests, cosmetic and allergy tests, and comprehensive health screening services. Our goal is to help our clients prevent diseases, help detect specific diseases early, and maintain good health.
No Data
No Data